Novo Holdings acquires stake in AGNEXT Technologies with advisory from Khaitan & Co
Acquiring Company
Novo Holdings
Acquired Company
AGNEXT Technologies
Hellerup
ChandigarhBiotechnologyHealth CareVenture CapitalLife ScienceInformation TechnologyFarmingDescription
Khaitan & Co provided advisory services to Novo Holdings in the acquisition of stake in AGNEXT Technologies. The advisory included structuring, due diligence, transaction documentation, and closing, with a core team and assistance from various legal aspects.
Quick answer
Novo Holdings is acquiring AGNEXT Technologies, announced July 2, 2024. Novo Holdings is based in Hellerup, Hovedstaden, Denmark.
- How much did Novo Holdings pay for AGNEXT Technologies?
- The deal value was not disclosed.
- What does Novo Holdings do?
- Novo Holdings A/S is a leading international healthcare and life sciences investor wholly owned by the Novo Nordisk Foundation.
- Where are Novo Holdings and AGNEXT Technologies based?
- Novo Holdings is based in Hellerup, Hovedstaden, Denmark. AGNEXT Technologies is based in Chandigarh, Chandigarh, India.
- Who are the decision-makers at Novo Holdings?
- Fundz holds 1 contact at Novo Holdings. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Venture Capital and Life Science
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Novo Holdings A/S to acquire Catalent, Inc. for $63.50 per share in cash (May 29, 2024)
- Leapcure Acquires Honeybee Trials: Enhancing Patient Engagement and Research Site Solutions (August 13, 2024)
- Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical (August 9, 2024)
- SurgNet Health Partners, Inc. completes acquisition of Tuscaloosa Endoscopy Center to advance care and patient experience (August 8, 2024)
- Eximia Research Network completes acquisition of Tidewater Clinical Research to expand its national clinical trial site network (August 2, 2024)
- Aditxt to acquire Appili Therapeutics, Inc. with a closing target of September 30 (July 25, 2024)
Who to call at Novo Holdings, and when
When Novo Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Novo Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novo Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novo Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novo Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired AGNEXT Technologies?
AGNEXT Technologies was acquired by Novo Holdings, based in Hellerup. The deal was reported on July 2, 2024. Novo Holdings A/S is a leading international healthcare and life sciences investor wholly owned by the Novo Nordisk Foundation. Novo Holdings is privately held and operates in Biotechnology.
When did Novo Holdings acquire AGNEXT Technologies?
Novo Holdings's acquisition of AGNEXT Technologies was reported on July 2, 2024. Khaitan & Co provided advisory services to Novo Holdings in the acquisition of stake in AGNEXT Technologies. The advisory included structuring, due diligence, transaction documentation, and closing, with a core team and assistance from various legal aspects. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does AGNEXT Technologies do?
AgNext is a fast-growing AgTech company that aims to solve quality and trust in food value chains by making them safer, transparent and fairer. It is privately held, operating in Information Technology, and is based in Chandigarh.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.